A groundbreaking new study has revealed a startling and largely ignored connection between a routine gynecological condition and the leading killer of women, suggesting that millions are being left unaware of a critical threat to their long-term health. Research published in the Journal of the American Heart Association found that women diagnosed with uterine fibroids—benign growths considered a normal part of female reproductive life—face an 81% higher risk of developing heart disease over the following decade.
"Uterine growths, also known as fibroids or myomas, are benign (non-cancerous) solid growths that develop in the uterus," said BrightU.AI's Enoch. "These growths can vary dramatically in size, from being very small to as large as a cantaloupe, and can occur singly or in multiples."
For women under 40, the risk is a staggering 3.5 times higher. This discovery, emerging from an analysis of over 2.7 million American women’s health records, challenges decades of medical compartmentalization and demands a fundamental shift in how women’s health is managed.
For generations, uterine fibroids have been dismissed by many clinicians as a benign nuisance, affecting up to 80% of women by age 50. The primary focus has been on managing symptoms like heavy bleeding or pelvic pain. The new research, led by scientists at the University of Pennsylvania, shatters that complacency. By comparing 450,177 women with fibroids to 2.25 million without, the team tracked the onset of major cardiovascular events.
The data paints a concerning picture. Within just one year of a fibroid diagnosis, affected women showed 2.47 times the cardiovascular risk of their peers. The gap widened over time. A decade out, 5.42% of women with fibroids had suffered a heart attack, stroke, or similar emergency, compared to only 3% of women without fibroids. Every component of cardiovascular disease was elevated, indicating a systemic problem, not a coincidence.
Perhaps the most alarming finding centers on younger women. Those diagnosed with fibroids before the age of 40 exhibited the most dramatic risk elevation. Their 3.5-fold higher likelihood of cardiovascular disease a decade later suggests that the biological processes linking these conditions begin causing silent damage early. This is a population typically considered low-risk by traditional cardiology metrics, yet they may be walking with a significant, unaddressed threat.
The connection is not random. The study underscores that fibroids and cardiovascular disease are rooted in identical biological pathways. Both conditions involve smooth muscle cells proliferating abnormally, fibrosis and calcification.
Critically, fibroids act as factories for inflammatory proteins. These substances flood the bloodstream, creating a state of chronic, body-wide inflammation—a known driver of atherosclerosis, the plaque buildup that causes heart attacks and strokes.
Furthermore, women with fibroids often share a dangerous metabolic profile: a tendency toward insulin resistance, unfavorable cholesterol levels, obesity and high blood pressure. The fibroid may be a visible symptom of this underlying metabolic dysfunction, which also relentlessly attacks the vascular system.
This research exposes a critical flaw in modern healthcare: its extreme specialization. A gynecologist manages the uterus, a primary care doctor checks cholesterol, and a cardiologist waits for traditional risk factors to appear. No single practitioner is trained to connect these dots. The body is treated as a collection of unrelated systems, leaving patients—especially women—vulnerable to having clear warning signs overlooked.
The historical context is profound. Women's health, particularly concerning reproductive organs, has long been siloed away from "serious" medicine like cardiology. Symptoms are often minimized, and conditions like fibroids are normalized to the point where their potential systemic implications are never explored. This study is a clarion call to end that fragmentation.
For the millions of women with fibroids, this news is a powerful catalyst for proactive health management. It means cardiovascular protection should begin at diagnosis. This involves strategies that address the root causes shared by both conditions.
An anti-inflammatory diet is paramount, emphasizing wild-caught fatty fish, organic berries, dark leafy greens and extra virgin olive oil while eliminating processed foods and refined sugars. Strategic supplementation with nutrients like CoQ10, nattokinase and magnesium can support vascular health. Addressing insulin resistance through a balanced diet and reducing exposure to endocrine-disrupting chemicals is also essential.
The findings mandate that a fibroid diagnosis should automatically trigger a comprehensive cardiovascular risk assessment. This includes advanced lab tests that can detect arterial inflammation and damage early. It requires healthcare providers to view a woman’s body as an interconnected whole.
The study concludes that uterine fibroids are associated with a sustained increase in cardiovascular risks for at least a decade after diagnosis. This isn't merely a statistical association; it's an early warning system embedded in women's bodies that medicine has, until now, failed to decode. For millions of women, understanding this link transforms a "routine" gynecological finding into a critical opportunity to preserve their heart health and rewrite their long-term health destiny.
Watch and learn about natural ways to treat uterine fibroids.
This video is from the Holistic Herbalist channel on Brighteon.com.
Sources include: